Loading…
YD Bio Ltd is projected to decline to $3.43 by 2027, a -13% move from its current price of $3.94. YDES is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.77 | $3.94 | $4.11 | -0.03% |
| May 30 | $3.71 | $3.94 | $4.18 | -0.06% |
| May 31 | $3.66 | $3.94 | $4.24 | -0.08% |
| Jun 1 | $3.61 | $3.94 | $4.29 | -0.11% |
| Jun 2 | $3.58 | $3.93 | $4.33 | -0.14% |
| Jun 3 | $3.54 | $3.93 | $4.37 | -0.17% |
| Jun 4 | $3.51 | $3.93 | $4.40 | -0.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.51 | $3.93 | $4.40 | -0.19% |
| Week 2 | $3.34 | $3.92 | $4.61 | -0.39% |
| Week 3 | $3.22 | $3.92 | $4.77 | -0.58% |
| Week 4 | $3.12 | $3.91 | $4.90 | -0.78% |
| Week 5 | $3.03 | $3.90 | $5.03 | -0.97% |
| Week 6 | $2.95 | $3.89 | $5.14 | -1.16% |
| Week 7 | $2.88 | $3.89 | $5.24 | -1.36% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
YD Bio Ltd is a biopharmaceutical company focused on blood-based cancer detection and the development of stem cell- and exosome-based therapeutics to transform the treatment of a spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan. It operates in the Healthcare sector.
YD Bio Ltd (YDES) is a healthcare stock with a current price of $3.94, a market cap of $279.08M, and a ranking of 3546 by market capitalization. This positions the company as a smaller-cap healthcare name with a focus on diagnostics and targeted therapeutics.
A major floor 25.7% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 38.6% above — a clean break opens room to run.
A major ceiling 213.7% above — clearing it would confirm fresh momentum.
Key YDES support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of YDES market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.41 | Sell | $4.39 | Sell |
| MA 10 | $4.76 | Sell | $4.64 | Sell |
| MA 20 | $4.96 | Sell | $4.94 | Sell |
| MA 50 | $5.76 | Sell | $5.92 | Sell |
| MA 100 | $8.00 | Sell | $7.57 | Sell |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 26.47 | Buy |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -236.40 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -25.80 | Sell |
| Bollinger %B (20,2) | -0.21 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.89 | Sell |
| Awesome (5,34) | -0.76 | Sell |
| Ultimate (7,14,28) | 18.67 | Buy |
| Momentum (10) | -1.25 | Sell |
| Aroon Osc (25) | -84.00 | Sell |
| Hull MA (9) | 4.19 | Sell |
| ADX (14) | 28.75 | Sell |
| ATR (14) | 0.20 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 30 and the 50-day simple moving average at $5.76. The stock shows a short-term support level at $3.94 and a resistance at $5.46, with a 30-day price range from $2.97 to $5.22.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.94 | $3.94 | $5.32 | 0% | Neutral | |
| $2.37 | $3.43 | $5.39 | -13% | Neutral | |
| $2.78 | $4.33 | $7.29 | +10% | Neutral | |
| $2.92 | $4.86 | $8.62 | +23% | Bullish | |
| $2.81 | $4.97 | $9.21 | +26% | Bullish | |
| $2.72 | $5.09 | $9.80 | +29% | Bullish | |
| $2.44 | $4.82 | $9.61 | +22% | Bullish | |
| $2.24 | $4.68 | $9.61 | +19% | Neutral | |
| $2.05 | $4.51 | $9.51 | +14% | Neutral | |
| $2.44 | $5.42 | $11.72 | +38% | Bullish | |
| $2.77 | $6.15 | $14.14 | +56% | Bullish | |
| $5.92 | $13.16 | $30.27 | +234% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $3.94 | $3.94 | $4.68 | +0.00% |
| June 2026 | $3.10 | $3.75 | $4.72 | -4.73% |
| July 2026 | $3.11 | $3.84 | $4.98 | +2.34% |
| August 2026 | $3.17 | $3.97 | $5.27 | +3.48% |
| September 2026 | $2.99 | $3.80 | $5.14 | -4.28% |
| October 2026 | $2.84 | $3.65 | $5.01 | -4.04% |
| November 2026 | $2.89 | $3.76 | $5.24 | +3.13% |
| December 2026 | $2.87 | $3.77 | $5.32 | +0.25% |
Click any year to see its month-by-month YDES forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
YD Bio Ltd's 2026 outlook centres on $3.94, within a $3.94 to $5.32 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, YDES could reach as high as $5.39, with a base case around $3.43 and support toward $2.37 — roughly -13% from $3.94. A consolidation phase looks the most probable path here.
Expect YDES to range from $2.78 to $7.29 through 2028. The $4.33 average target implies a +10% move from current prices. That is up +26% on the projected 2027 average. Price action looks broadly range-bound.
The YDES price prediction for 2029 points to an average of $4.86 (low $2.92, high $8.62) — a potential gain of +23% on today's $3.94. Buyers look set to stay in control over this stretch.
In 2030, YDES is projected to trade between $2.81 and $9.21, averaging $4.97 — a potential gain of +26% from today's $3.94. That is up +2% on the projected 2029 average. Momentum favours further upside here.
YD Bio Ltd's 2031 outlook centres on $5.09, within a $2.72 to $9.80 range. That is up +2% on the projected 2030 average. That marks a +29% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, YDES could reach as high as $9.61, with a base case around $4.82 and support toward $2.44 — roughly +22% from $3.94. Momentum favours further upside here.
Expect YDES to range from $2.24 to $9.61 through 2033. The $4.68 average target implies a +19% move from current prices. That is -3% versus the projected 2032 average. A consolidation phase looks the most probable path here.
The YDES price prediction for 2034 points to an average of $4.51 (low $2.05, high $9.51) — a potential gain of +14% on today's $3.94. Price action looks broadly range-bound.
In 2035, YDES is projected to trade between $2.44 and $11.72, averaging $5.42 — a potential gain of +38% from today's $3.94. That is up +20% on the projected 2034 average. Buyers look set to stay in control over this stretch.
YD Bio Ltd's 2040 outlook centres on $6.15, within a $2.77 to $14.14 range. That is up +13% on the projected 2035 average. That marks a +56% change versus current levels. Momentum favours further upside here.
By 2050, YDES could reach as high as $30.27, with a base case around $13.16 and support toward $5.92 — roughly +234% from $3.94. Buyers look set to stay in control over this stretch.
Investing $1,000 in YDES today (≈ 253.807107 YDES) could be worth
$3,340.74
+$2,340.74 (+234%) by 2050 · US Dollar
Based on the average projected YDES price of $13.16 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in YDESwould be worth at today's price.
$1,000 invested in YDES on Aug 26, 2025 (≈ 74.850301 YDES) would be worth
$294.91
-$705.09 (-70.5%) today · 0.29× · US Dollar
Based on a YDES entry price of $13.36 vs. today's $3.94.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.55 | $865.93 | -13.4% |
| 1 month ago | $5.46 | $721.61 | -27.8% |
| 3 months ago | $9.03 | $436.32 | -56.4% |
| 6 months ago | $11.53 | $341.72 | -65.8% |
| All time ago | $13.36 | $294.91 | -70.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our YDES forecast.
Our base-case forecast reaches $7.90 around 2050.
Implied market cap at $7.90: $559.57M
The multi-year forecast shows a path from neutral to bullish over time. In 2026 the min, avg, and max are $3.94, $3.94, and $5.32 respectively (ROI 0, sentiment Neutral). The forecast then shows growth potential with 2027 (min $2.37, avg $3.43, max $5.39; ROI -12.9, Sentiment Neutral) giving way to stronger upside in 2028–2032, culminating in 2050 with min $5.92, avg $13.16, max $30.27 and ROI 234.1 (Sentiment Bullish).
Key milestones include 2029 (avg $4.86, max $8.62; ROI 23.3; Bullish) and 2030 (avg $4.97, max $9.21; ROI 26.1; Bullish). The path also shows meaningful upside by 2040 (avg $6.15, max $14.14; ROI 56; Bullish). These figures imply potential longer-term appreciation but come with varying annual returns and risk.
Tap a question to reveal the answer.
2030 forecast: min $2.81, avg $4.97, max $9.21; ROI 26.1; sentiment Bullish.
Forecasts show several years with Bullish sentiment and positive ROI, including 2029 (ROI 23.3), 2030 (ROI 26.1), 2031 (ROI 29.1), and 2050 (ROI 234.1). These are estimates and not guarantees.
Yes. The 30-day high is $5.22 and the 2029 max is $8.62, with 2030 max at $9.21.
2040 forecast: min $2.77, avg $6.15, max $14.14; ROI 56; sentiment Bullish.
2050 forecast: min $5.92, avg $13.16, max $30.27; ROI 234.1; sentiment Bullish.
YD Bio Ltd Community Discussion
0Share your YD Bio Ltd price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.